Category 1 Focus Group Meeting

Meeting Objectives:

Date & Time


  • To share experiences and best practices in in vitro (category 1) assessments of abuse deterrent formulations

  • To discuss standardization of in vitro (category 1) studies and limits associated with established standard practices

  • To provide an open forum or society enabling discussion on the FDA Guidance for Industry: Abuse Deterrent Opioids – Evaluation and Labeling

  • To provide an opportunity for presentations by academia, regulatory and industry experts focused in the Category 1 field 

Renaissance Mayflower Hotel
1127 Connecticut Ave NW, Washington, DC 20036
(202) 347-3000

November 4, 2015

8:30 am - 5:10 pm (EST)